@Barman76 yes everyone should stop trotting out garbage re trial results and state the facts:
"CYP cells resulted in an improvement in GvHD severity by at least one grade for 87% of patients by day 100, and a complete response by day 100 in 53% of patients".
"MSB cells, despite using dosages that were multiples the size used in CYP trials, did not find great results but they would have found better results if they tried a different sample, or maybe they would have not".
Is that an ok correction for you?
Ann: Cynata Extends FUJIFILM Licence Option in GvHD, page-230
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 25.0¢ | $3.097K | 12.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29341 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 11015 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |